ABAC Therapeutics
Antoni Torrens has extensive work experience in the pharmaceutical industry. Antoni is currently employed at ABAC Therapeutics as the Senior Vice President of Medicinal Chemistry, a position they started in January 2021. Prior to this, they worked at Esteve for over three decades, starting in November 1988. During their time at Esteve, they held the role of Head of Chemical Collaborations & Strategic Alliances until June 2023.
Antoni Torrens attended Universitat de Barcelona, although the specific start and end years of their education remain unknown. The degree pursued and field of study are also unspecified.
This person is not in any teams
ABAC Therapeutics
ABAC Therapeutics is aimed at seeking first-in-class drugs for precision treatment of MDR Gram-negative infections. While potent pathogen-specific antibacterial activity is essential, we believe that it is necessary to incorporate early other pharmaceutical properties, such as suitable pharmacokinetics and toxicological characteristics, to maximizethe chance of success in clinical development.